Rebeccamycin Completed Phase 2 Trials for Recurrent Breast Cancer / Breast Cancer, Stage IIIB / Male Breast Cancer / Carcinoma Breast Stage IV Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00005817Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer